# Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.

> **NCT03941808** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 50 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Glisodin tablet
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT03941808
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-17
- **Primary completion:** 2020-05-02
- **Final completion:** 2020-12-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03941808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03941808, "Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03941808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*